James River Group Holdings, Inc. current report, 08 November 2017

Business Context and Reporting Period

This Form 8-K Current Report was filed by James River Group Holdings, Ltd. on November 8, 2017. The filing reports a significant corporate event involving the sale of common shares by existing shareholders rather than a primary offering by the Company.

Key Financial Metrics

The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the terms of a secondary share offering.

  • Shares Sold: 3,000,000 common shares.
  • Offering Price: $38.10 per share.
  • Over-Allotment Option: 30-day option to purchase up to an additional 450,000 shares.
  • Proceeds to Company: $0 (The Company will not receive any proceeds from this transaction).

Material Changes

The material change reported is the execution of an Underwriting Agreement on November 8, 2017. Selling Shareholders (D. E. Shaw Affiliates and J. Adam Abram) agreed to sell their shares to Morgan Stanley & Co. LLC. This transaction represents a change in ownership structure for the selling parties but does not alter the Company's capital structure or cash position.

Guidance, Outlook, and Risks

The filing contains no management commentary, financial guidance, or outlook for future periods. The document notes customary representations, warranties, and indemnification provisions within the Underwriting Agreement regarding liabilities under the Securities Act of 1933. No specific risks or contingencies related to the Company's operations are detailed in this report.

Investor Verification Checklist

  • Verify the identity of the Selling Shareholders (D. E. Shaw Affiliates and J. Adam Abram) and their remaining holdings post-transaction.
  • Confirm that the Company received no proceeds from the $38.10 per share sale price.
  • Review the attached Underwriting Agreement (Exhibit 1.1) for specific indemnification terms and customary conditions.
  • Check subsequent filings to determine if the 30-day over-allotment option for 450,000 shares was exercised.